Academic article

• Rineke de Jong; Fan Zhou; Tor Kristian Andersen et al. (2025). An HLAII-targeted DNA vaccine against influenza H7N9 protected mice and ferrets from a virus challenge. (external link)
• Thor Ueland; Rebecca Jane Cox; Annika Elisabet Michelsen et al. (2025). Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection. (external link)
• Johanna Eva Bodin; Gro Tunheim; Anja Bråthen Kristoffersen et al. (2025). High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza. (external link)
• Fan Zhou; Lena Hansen; Gabriel Kristian Pedersen et al. (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. (external link)
• Trung Tran; Eline Benno Vaage; Adi Mehta et al. (2022). Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. (external link)
• Lena Hansen; Karl Albert Brokstad; Amit Bansal et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (external link)
• Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2016). Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.. (external link)
• Nina Urke Ertesvåg; Julie Xiao; Fan Zhou et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (external link)
• Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (external link)
• Håkon Amdam; Anders Madsen; Fan Zhou et al. (2021). Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). (external link)
• Tor Kristian Andersen; Fan Zhou; Rebecca Jane Cox et al. (2017). A DNA vaccine that targets hemagglutinin to antigen-presenting cells protects mice against H7 influenza. (external link)
• Therese Bredholt Onyango; Fan Zhou; Geir Bredholt et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (external link)
• Joanna Waldock; Edmond J. Remarque; Lingyi Zheng et al. (2023). Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study. (external link)
• Juan Manuel Carreño; Jacqueline U. McDonald; Tara Hurst et al. (2020). Development and assessment of a pooled serum as candidate standard to measure influenza a virus group 1 hemagglutinin stalk-reactive antibodies. (external link)
• Julie Zimmermann; Signe Tandrup Schmidt; Ramona Trebbien et al. (2022). A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease. (external link)
• Federica Sicca; Eleni Sakorafa; Anouk de Jonge et al. (2022). The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority. (external link)
• Anders Madsen; Linda Azimi; Sarah Tete et al. (2019). No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. (external link)
• Marie-Clotilde Bernard; Joanna Waldock; Sylvie Commandeur et al. (2022). Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study. (external link)
• Geir Bredholt; Marianne Sævik; Hanne Søyland et al. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. (external link)
• Mai Chi Trieu; Amit Bansal; Anders Madsen et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
• Camilla Tvedt Ekanger; Nilima Dinesh Kumar; Rosanne W. Koutstaal et al. (2025). Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies. (external link)
• Hongxing Hu; Fan Zhou; Xiaoli Ma et al. (2025). Targeted barcoding of variable antibody domains and individual transcriptomes of the human B-cell repertoire using Link-Seq. (external link)
• Sarah Larteley Lartey; Rishi Pathirana; Fan Zhou et al. (2015). Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. (external link)
• Shahinul Islam; Kristin Greve Isdahl Mohn; Florain Krammer et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (external link)
• Shahinul Islam; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (external link)
• Martin Beukema; Shuran Gong; Kasem Al-Jaawni et al. (2023). Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice. (external link)
• Elisabeth Berg Fjelltveit; Bjørn Blomberg; Kanika Kuwelker et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (external link)
• Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2018). Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)
• Sehee Rim; Sunniva Todnem Sakkestad; Fan Zhou et al. (2023). Dynamics of circulating lymphocytes responding to human experimental enterotoxigenic Escherichia coli infection. (external link)
• Karl Albert Brokstad; Marita Fredriksen; Fan Zhou et al. (2018). T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome. (external link)
• Kanika Kuwelker; Fan Zhou; Bjørn Blomberg et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (external link)
• Fan Zhou; Juha Vahokoski; Siri Øyen et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (external link)
• Kristin Greve-Isdahl Mohn; Geir Bredholt; Fan Zhou et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (external link)
• Lena Hansen; Fan Zhou; Håkon Amdam et al. (2021). Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers. (external link)
• Camilla Tvedt Ekanger; Fan Zhou; Dana Bohan et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (external link)
• Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Fan Zhou et al. (2024). Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine. (external link)
• Bjørn Blomberg; Kristin Greve-Isdahl Mohn; Karl Albert Brokstad et al. (2021). Long COVID in a prospective cohort of home-isolated patients. (external link)
• Monica Trondsen; Lara Adnan Aqrawi; Fan Zhou et al. (2015). Induction of local secretory IgA and multifunctional CD4+ T-helper cells following intranasal immunization with a H5N1 whole inactivated influenza virus vaccine in BALB/c mice. (external link)
• Nina Urke Ertesvåg; Sunniva Todnem Sakkestad; Fan Zhou et al. (2022). Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment. (external link)
• Kristin Greve Isdahl Mohn; Fan Zhou; Karl Albert Brokstad et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (external link)
• Mai Chi Trieu; Åsne Jul-Larsen; Marianne Sævik et al. (2018). Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: A 5-year follow-up study. (external link)
• Sarah Larteley Lartey Jalloh; Fan Zhou; Karl Albert Brokstad et al. (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. (external link)
• Amit Bansal; Mai Chi Trieu; Emily M. Eriksson et al. (2025). SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis. (external link)

Conference lecture

• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Low infection and seroconversion rates in frontline healthcare workers during the peak of the Coronavirus disease 2019 pandemic in Bergen, Norway. (external link)
• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). SARS-COV-2-Specific neutralising antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Antibody responses to SARS-CoV-2 virus in Norwegian health-care workers: an observational prospective cohort study. (external link)
• Sehee Rim; Sunniva Todnem Sakkestad; Fan Zhou et al. (2019). Comprehensive characterization and kinetics of circulating lymphocytes in human volunteers experimentally infected with enterotoxigenic Escherichia coli. (external link)
• Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Fan Zhou et al. (2015). Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.. (external link)
• Sehee Rim; Sunniva Todnem Sakkestad; Fan Zhou et al. (2022). Dynamics of circulating lymphocytes responding to human experimental enterotoxigenic Escherichia coli infection. (external link)
• Fan Zhou; Juha Vahokoski; Florian Krammer et al. (2023). Age related differences in kinetics and magnitude of SARS-CoV-2 and endemic human coronavirus reactive antibody responses after vaccination and infection. (external link)

Academic literature review

• Fan Zhou; Mai Chi Trieu; Richard Allan Davies et al. (2018). Improving influenza vaccines: challenges to effective implementation. (external link)
• Kristin Greve Isdahl Mohn; Fan Zhou (2018). Clinical expectations for better influenza virus vaccines - perspectives from the young investigators' point of view. (external link)

Conference poster

• Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Kristin Greve-Isdahl Mohn et al. (2023). A Comparison of Humoral Responses Induced Following Live Attenuated Influenza Vaccination in Children and Adults. (external link)
• Lukas Anders Kryger Hoen; Camilla Tvedt Ekanger; Fan Zhou et al. (2024). Influenza A Variants Formed During Lung Organoid Infection In The Presence of Humoral Immunity. (external link)
• Lena Hansen; Fan Zhou; Håkon Amdam et al. (2019). Neuraminidase antibody responses after pandemic and seasonal influenza vaccinations: a five-year study. (external link)
• Camilla Tvedt Ekanger; Fan Zhou; Karl Albert Brokstad et al. (2024). Comparison of Air-Liquid Interface and Organoid Airway Models for Human Respiratory Virus Infection Studies. (external link)
• Fan Zhou; Juha Vahokoski; Nina Langeland et al. (2022). Kinetics of seasonal and pandemic human coronavirus reactive antibodies after repeated vaccinations in adults and the elderly. (external link)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2024). Phenotypic and functional changes of human follicular T helper cells over decades of life. (external link)
• Sehee Rim; Sunniva Todnem Sakkestad; Jørn Skavland et al. (2018). Comprehensive characterization of circulating T follicular helper cells and plasmablasts in human volunteers experimentally infected with enterotoxigenic Escherichia coli. (external link)
• Lena Hansen; Fan Zhou; Rebecca Jane Cox (2019). Neuraminidase Antibody Responses After Pandemic And Seasonal Vaccination: A Five-Year Study. (external link)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Age related decline of T follicular helper cells in children and adults. (external link)
• Fan Zhou; Steffen Aleksander Slettevoll; Sarah Larteley Lartey Jalloh et al. (2017). Live attenuated in+luenza vaccine elicits superior follicular T help cell and local antibody responses in children. (external link)
• Fan Zhou; Lena Hansen; Tor Kristian Andersen et al. (2019). Adjuvanted H5N1 vaccine elicits rapid and multifaceted humoral immune responses in human. (external link)
• Fan Zhou; Lena Hansen; Gabriel Pedersen et al. (2022). Matrix M adjuvanted H5N1 vaccine elicits broadly neutralizing antibodies and neuraminidase inhibiting antibodies in humans that correlate with in vivo protection. (external link)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2015). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (external link)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (external link)

Letter to the editor

• Kristin Greve-Isdahl Mohn; Geir Bredholt; Therese Bredholt Onyango et al. (2023). SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity. (external link)

Journal corrigendum

• Trung Tran; Eline Benno Vaage; Adi Mehta et al. (2023). Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants (npj Vaccines, (2022), 7, 1, (174), 10.1038/s41541-022-00586-7). (external link)
• Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2018). Publisher Correction: Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)

See a complete overview of publications in NVA.